ReviewJournal of translational medicine2022

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.

Bing-Tao Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.